跳至主要内容

Rifampicin Hebei Xingang Pharmaceutical Co Ltd

We are committed to relieving the disease and suffering of TB patients who account for one-third of the world's total population. We have worked closely with scientists, medical scientists, and doctors to develop and produce Rifampicin, the first-line drug of choice for treating tuberculosis. Treatment practice concludes that Rifampicin is the irreplaceable first-choice drug in anti-tuberculosis in terms of treatment effect and production process maturity. Our Rifampicin production accounts for more than 60% of the global market share, meeting the treatment needs of the United States, Canada, and Mexico in North America, Germany, Russia, and Ukraine in Europe, South Korea, Thailand, India, Pakistan, Vietnam and Indonesia in Asia, Brazil in Latin America and African countries.


rifampicin capsules Hebei Xingang Pharmaceutical Co Ltd Rifampicin API manufacturer producer supplier 

Rifampicin is an antibiotic that is commonly used together with other medications for the treatment of tuberculosis (TB).

Tuberculosis is an infection caused by the bacterium Mycobacterium tuberculosis. You can get infected by breathing in droplets containing this bacterium that are sprayed into the air when an infected person coughs or sneezes.

There are two types of tuberculosis:

1. Active TB
An infection with M. tuberculosis could present with symptoms. It is possible to spread the infection when you have active tuberculosis that is not treated.
Common signs and symptoms include coughing for more than three weeks, may be coughing up blood, fever, night sweats, loss of appetite, weight loss, pain in the chest.
Your doctor may do an X-ray of your chest to observe for any unusual signs in your lungs, or a phlegm test to check for the presence of the tuberculosis bacteria under the microscope.
Usually treated with a combination of the following four medications: Rifampicin, Isoniazid, Ethambutol and Pyrazinamide. These medications can work together to kill the tuberculosis bacteria.

2. Latent TB
An infection with tuberculosis bacteria but with NO symptoms.
If you have latent TB, you cannot spread it to another person.
Usually treated with either Isoniazid or Rifampicin.
You might have to take the medication for six to nine months. For active tuberculosis, the first two months usually consists of a combination of the four medications stated above, and the remaining four to seven months is completed using the two medications, Rifampicin and Isoniazid. Do not miss any dose of medication. This may lead to a relapse or worsening of tuberculosis, or a condition with a more resistant form of tuberculosis. In such cases, a longer duration of treatment or use of stronger medications may be needed.

Depending on your condition, you may need to attend Directly Observed Therapy (DOT) sessions to help you complete your course of treatment. DOT refers to a healthcare worker or trained volunteer supervising the patient taking each dose of tuberculosis medications. The number of DOT sessions can range from once a day to three times a week.

评论

此博客中的热门博文

Zeigarnik effect

  As a freelancer, you have to fight procrastination every day. "I've made up my mind many times, but I just can't change it. Is it because I'm slow or slow?". In fact, many procrastinations are irrational. Many obstructions are imagined by myself. So distract, postpone, avoid confrontation. It's cool to procrastinate, and it's cool to procrastinate all the time, so I can't do it. Concentration is also related to physical strength. When the physical strength is exhausted, it is even more difficult to concentrate. You’ll tell yourself: I’m too tired to do this—okay, another perfect procrastination.   In 1927, Bruma Zeigarnik's senior research found that people are more likely to care about unfinished and interrupted work than completed work. This is the Zeigarnik effect. For example, we often don't care much about what we have got, but we will especially cherish what we have worked hard but haven't got. Therefore, the TV series will tell you

Moroccan football team: "The most familiar stranger"

   When I was still in college ten years ago, I led a sightseeing group of more than 30 Moroccan students. Before meeting them, my general impression of the Moroccans was that they are from North Africa but closer to the Arab world. They have religious beliefs, are used to worship, and are inextricably linked with France.   When I saw the real person, I realized that the North Africans in front of me were actually a group of children playing with each other and having fun in time. They were about the same age as me at the time. I have all kinds of nicknames and nicknames. During the process of taking them to Badaling, the Summer Palace and Houhai, two classmates and I, together with more than 30 Moroccan students, realized "cultural integration" and "world unity" in the small group to some extent.   During the World Cup in Qatar, I was surprised to find that the little-known Morocco team, which was eliminated in the group stage of the last World Cup, after miraculou

Your appearance determines whether you can be studied

   Everyone has a love of beauty—scientists are no exception.   In May 2021, a study published in "Nature Plants" (Nature Plants) found that those beautiful flowers have more chances to become the research objects chosen by researchers. In other words, appearance not only affects finding a partner, but also affects whether one can become a subject of research.   In fact, not only appearance, but also many factors will cause researchers to be unable to treat all research objects equally. The sense of existence of different species is really different, and the well-known species have a higher chance of being studied. Everyone has probably heard of the koala (Phascolarctos cinereus), but how many of you know the less popular but more endangered Queensland hairy-nosed wombat (Lasiorhinus krefftii)? There are more than 5,000 papers on koalas that can be searched on Google Scholar, and 616 related pictures on Wikimedia Commons; while papers on Queensland wool-nosed wombats are less